Aug 2026· British Journal of Cancer· 0 citations· 28 references
Medicine
TL;DR
An internally validated prediction model for BrM in GI cancers developed and validated performance in a held-out cohort to develop a clinically interpretable prediction model.
Among patients treated with NAC for early-stage BC, residual nodal disease, inflammatory BC, and HER2+ or triple-negative subtype are associated with a higher risk of BrM development and whether BrM screening is warranted among patients with these high-risk features warrants evaluation.
Jie Zhu, I. Fernandes, Júlia Belone Lopes et al.· Journal of Neuro-Oncology· 0 citations
Background Lung cancer with brain metastasis (LCBM) significantly shortens patient survival. Accurately predicting individual prognosis remains challenging. This study aimed to identify key prognostic factors in LCBM patients after radiotherapy for the development of an interpretable machine learning (ML) model to supp...
Ru Song, Zhi-Jun Zhang, Xia-Oou Huo et al.· Journal of Thoracic Disease· 0 citations
Abstract Background Obesity is characterized by chronic low-grade systemic inflammation and altered metabolic signaling, which may disrupt periphery-to-brain communication and compromise central nervous system interfaces. These obesity-associated inflammatory perturbations may influence tumor seeding and the phenotypic...
C. Murphy, Bo Zhang, Júlia Belone Lopes et al.· Neuro-Oncology Advances· 0 citations
OBJECTIVE
The objective of the present study was to explore the prevalence, risk and prognostic factors for bone metastases (BM) developement in patients with initial gastric cancer (GC).
METHODS
A total of 30,817 patients with GC in the Surveillance, Epidemiology and End Results (SEER) database, diagnosed from 2010...
Thanh Tùng Hoàng, Tuấn Sỹ Anh Bùi, Manh Nguyen et al.· Asian Pacific Journal of Can...· 0 citations
Objective To develop and validate a predictive model integrating patient demographics and clinical data for estimating 3-, 4-, and 5-year overall survival in patients with locally advanced cervical squamous cell carcinoma (LACSC). Methods Clinical data from 670 LACSC patients at Shanxi Cancer Hospital were collected an...
Ting-Ting Zou, Xu-Peng Wang, Hai-Xia Wu et al.· Frontiers in Oncology· 0 citations
A clinical model incorporating age (≥65 years), T stage (T3/T4), N stage (N2/N3), and chemotherapy (no) was developed to predict inferior OS in early-stage MedBC.
Y. Tan, X. Tian, Q. Li et al.· Hong Kong medical journal =...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.